
Bradley Z. Naifeh Inaugural Amyloidosis Conference - Medical Professionals - LIVESTREAM (VIRTUAL ONLY)
LIVESTREAM (virtual) attendance
Houston Methodist J.C. Walter Conference Series
Presented by: Bradley Z. Naifeh Amyloidosis Clinical Research and Treatment Program at Houston Methodist J.C. Walter Jr. Transplant Center
Amyloidosis is an underrecognized condition because it has been historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics has made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.
FEES
REGISTRATION TYPE | FEE |
---|---|
Physician (HM, MPAQ, ACO PCP) | Complimentary |
Physician (Private physician located within the Greater Houston Area) | $230 |
Physician (Private physician located within the Greater Houston Area; NO CE) Click here to register! | Complimentary |
Physician (Private physician located outside the Greater Houston Area) | Complimentary |
Allied Health Care Professionals | Complimentary |
Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Cardiologists, hematologists, neurologists. nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities.
Learning Objectives
Upon completion of this course, the participant should be able to:
- Discuss the two major kinds (AL and TTR) of amyloidosis and appropriate diagnosis and categorization of these kinds.
- Identify how to investigate the various organ involvement in Amyloidosis.
- Discuss the current approved therapies for the two major kinds of amyloidosis (AL and TTR).
- Describe the potential future therapies for both TTR and AL amyloidosis.
Time | Presentation | Speaker(s) |
8:00 AM | Leadership Welcome: Mission of the Transplant Center | R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed) |
8:05 AM | Conference Introduction | Co-Directors Arvind Bhimaraj, MD, MPH, FACC, FHFSA Barry H. Trachtenberg, MD, FACC |
8:10 AM | History of Amyloidosis Treatment in the Transplant Center | A. Osama Gaber, MD, FACS, FAST |
8:15 AM | Introduction of the Bradley Z. Naifeh Amyloidosis Program | Arvind Bhimaraj, MD, MPH, FACC, FHFSA |
8:20 AM | Special Presentation for the Naifeh Family | Arvind Bhimaraj, MD, MPH, FACC, FHFSA R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed) Barry H. Trachtenberg, MD, FACC Susan A. Zylicz, BSN, MHA, CCTC |
8:35 AM | A Message from the Naifeh Family | Valerie Naifeh |
PLENARY SESSION I: WHAT IS AMYLOIDOSIS? | ||
8:45 AM | What Is Amyloidosis and What is the Clinical Relevance? | Arvind Bhimaraj, MD, MPH, FACC, FHFSA |
9:00 AM | Understanding AL Amyloidosis-Clinical Presentations and Biological Implications of a Multisystem Disease | Vaishali Sanchorawala, MD |
9:25 AM | Recognizing TTR and Diagnostic Work Up for Cardiac Amyloidosis | Barry H. Trachtenberg, MD, FACC |
9:40 AM | Q&A and Discussion | |
9:55 AM | BREAK AND EXHIBITS | |
PLENARY SESSION II: COURSE OF ACTION: THE CURRENT AND FUTURE OF TREATMENT | ||
10:10 AM | Current Treatment Options for AL Amyloidosis | Kelty R. Baker, MD |
10:25 AM | Current and Future Treatment Options for TTR Amyloidosis Novel Therapies in Amyloidosis: Anti-Fibrils Strategies | Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM |
10:50 AM | FDA Perspective on New Therapies | Rosalyn Adigun, MD, PharmD |
11:10 AM | Q&A and Discussion | |
11:25 AM | LUNCH AND EXHIBITS | |
PLENARY SESSION III: AMYLOIDOSIS AND ORGAN INVOLVEMENT: HOW IT ALL RELATES | ||
12:25 PM | Amyloidosis in the Neurology World: Neuropathies, Autonomic Dysfunction and More | Sheetal Shroff, MBBS |
12:40 PM | Gastrointestinal Involvement and Management in Amyloidosis | Elizabeth Blaney, MD |
1:05 PM | Role of Orthopedic Providers for Early Diagnosis of Amyloidosis | Shari R. Liberman, MD |
1:20 PM | Renal Involvement in Amyloidosis | Horacio E. Adrogue, MD, FASN |
1:35 PM | Lung Involvement in Amyloidosis | |
1:50 PM | Solid Organ Replacement of End Organs in Amyloidosis: A Viable Option in Select Centers | |
2:10 PM | Q&A and Discussion | |
2:25 PM | BREAK AND EXHIBITS | |
PLENAEY SESSION IV: CASE-BASED LEARNING: AMYLOIDOSIS - AN ELUSIVE DISEASE | ||
2:40 PM | Case Presentation (Cardiac): Cardiogenic Shock and Bridge to Transplant | Presenter: Houston Methodist Fellow Panel: Houston Methodist Faculty |
3:05 PM | Closing Remarks | |
3:15 PM | Adjourn |
COURSE DIRECTORS |
Arvind Bhimaraj, MD, MPH, FACC, FHFSA |
Co-Director, Bradley Z. Naifeh Treatment and Research Program Associate Professor, Weill Cornell Medical School Co-Director, Heart Failure and Transplantation Translational Laboratory Director, Heart Failure Disease Management Service Division of Heart Failure, Transplantation and Mechanical Circulatory Support Cardiology Methodist DeBakey Cardiology Associates |
Barry H. Trachtenberg, MD, FACC |
Co-Director, Bradley Z. Naifeh Treatment and Research Program Advanced Heart Failure and Transplantation Member, Methodist Heart and Vascular Center Houston Methodist J.C. Walter Jr. Transplant Center Houston Cardiovascular Associates Heart Failure Co-Chair, Texas Chapter American College of Cardiology |
SPECIAL GUEST |
Valerie Naifeh |
GUEST FACUTLY |
Rosalyn Adigun, MD, PharmD, MSc |
Medical Officer Division of Cardiology and Nephrology U.S. Food and Drug Administration Silver Spring, Maryland |
Elizabeth Blaney, MD |
Associate Professor of Medicine Division of Gastroenterology Associate Program Director of Education Washington University School of Medicine St. Louis, Missouri |
Vaishali Sanchorawala, MD |
Professor of Medicine Director, Amyloidosis Center Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine Boston, Massachusetts |
Professor Ashutosh Wechalekar, MD, FRCP, FRCPath, DM |
Professor of Medicine and Haematology Consultant Haematologist Director, Jack O’Neil Amyloidosis Laboratory National Amyloidosis Centre|University College London (Royal Free Campus) Department of Haematology, University College London Hospitals Department of Haematology, Royal Free London NHS Foundation Trust London, England |
HOUSTON METHODIST FACULTY |
Horacio E. Adrogue, MD, FASN |
Associate Professor of Clinical Medicine, Academic Institute Associate Clinical Member, Research Institute Houston Methodist |
Kelty R. Baker, MD |
Hematologic Malignancy, Hematology Houston Methodist |
A. Osama Gaber, MD, FACS, FAST |
John F., Jr. and Carolyn Bookout Presidential Distinguished Chair in Surgery, Department of Surgery Chair, Department of Surgery Professor of Surgery Program Director, Transplant Surgery Fellowship, Department of Surgery Houston Methodist Weill Cornell Medical College |
R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed) |
J.C. Walter Jr. Presidential Distinguished Chair Director, J.C. Walter Jr. Transplant Center Director, Transplantation Research Chief, Division of Transplantation, Department of Surgery Professor of Surgery Weill Cornell Medical College Houston Methodist |
Shari R. Liberman, MD |
Hand & Upper Extremity Surgery Henrietta and Terence Hall Distinguished Centennial Clinical Academic Scholar in Orthopedic Surgery Program Director, Houston Methodist Department of Orthopedic Surgery Assistant Professor for Clinical Orthopedic Surgery, Weill Cornell Medical College Assistant Professor for Clinical Orthopedic Surgery, Texas A & M College of Medicine |
Sheetal Shroff, MBBS |
Assistant Professor of Clinical Neurology, Academic Institute Assistant Clinical Member, Research Institute Houston Methodist Weill Cornell Medical College |
Available Credit
- 4.75 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 4.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.75 Attendance
- 5.00 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award 5.00 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.
- 0.00 Transplant CoordinatorsThe American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Bradley Z. Naifeh Inaugural Amyloidosis Conference - Medical Professionals - LIVESTREAM (VIRTUAL ONLY) | Tue, 01/03/2023 - 8:00am | 0.00 Category 1 CEPTCs
Price
STEPS TO REGISTER:
- STEP 1 - Choose the appropriate fee and click the "Add to Cart" button to complete the checkout process.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
REGISTRATION TYPE | FEE |
---|---|
Physician (HM, MPAQ, ACO PCP) | Complimentary |
Physician (Private physician located within the Greater Houston Area) | $230 |
Physician (Private physician located within the Greater Houston Area; NO CE) Click here to register! | Complimentary |
Physician (Private physician located outside the Greater Houston Area) | Complimentary |
Allied Health Care Professionals | Complimentary |
Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.